Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) 3-Year EBITDA Growth Rate : 9.50% (As of Jun. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co 3-Year EBITDA Growth Rate?

Shandong Weigao Group Medical Polymer Co's EBITDA per Share for the six months ended in Jun. 2023 was $0.20.

During the past 12 months, Shandong Weigao Group Medical Polymer Co's average EBITDA Per Share Growth Rate was -16.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 9.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 15.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shandong Weigao Group Medical Polymer Co was 80.50% per year. The lowest was -25.00% per year. And the median was 22.25% per year.

Competitive Comparison of Shandong Weigao Group Medical Polymer Co's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Weigao Group Medical Polymer Co's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's 3-Year EBITDA Growth Rate falls into.

Shandong Weigao Group Medical Polymer Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Shandong Weigao Group Medical Polymer Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (OTCPK:SHWGY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SHWGF:USA 01066:Hong Kong UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines

From GuruFocus

ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products

By PRNewswire PRNewswire • 04-08-2019

Shandong Weigao Group Medical Polymer Co Ltd's Dividend Analysis

By GuruFocus Research • 10-26-2023